Barbara Uscinska
About
Barbara Uscinska is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Barbara Uscinska has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 10 papers in Surgery. Recurrent topics in Barbara Uscinska's work include Sarcoma Diagnosis and Treatment (11 papers), Urinary and Genital Oncology Studies (8 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Barbara Uscinska is often cited by papers focused on Sarcoma Diagnosis and Treatment (11 papers), Urinary and Genital Oncology Studies (8 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Barbara Uscinska collaborates with scholars based in United Kingdom, Netherlands and Belgium. Barbara Uscinska's co-authors include M. Nooij, M. van Glabbeke, R. J. Grimer, Alan Craft, Anne Kirkpatrick, Simon Weeden, Pancras C.W. Hogendoorn, Jeremy Whelan, Matthew R. Sydes and Ian Lewis and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.
In The Last Decade
Barbara Uscinska
22 papers receiving 1.4k citations
Peers
Barbara Uscinska
Rudolf Schwarz Germany
Janet Thomas United Kingdom
Rolf von Knobloch Germany
Naji Salem France
Eble Jn United States
Claudia Valverde Spain
Hemant Tongaonkar India
Tipu Nazeer United States
Daniel Kedar Israel
Kyle Molberg United States
Citations per year, relative to Barbara Uscinska Barbara Uscinska (= 1×)
peers
Rudolf Schwarz
Countries citing papers authored by Barbara Uscinska
Since
Specialization
Citations
This map shows the geographic impact of Barbara Uscinska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Uscinska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Uscinska more than expected).
Fields of papers citing papers by Barbara Uscinska
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Barbara Uscinska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Uscinska. The network helps show where Barbara Uscinska may publish in the future.
Co-authorship network of co-authors of Barbara Uscinska
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Uscinska. A scholar is included among the top collaborators of Barbara Uscinska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Uscinska. Barbara Uscinska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Griffiths, Gareth, Richard Cowan, Kenneth M. Grigor, et al.. (2019). BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract. PLoS ONE. 14(1). e0210785–e0210785.
2.
McTiernan, Anne, Rachel C. Jinks, Matthew R. Sydes, et al.. (2011). Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup. European Journal of Cancer. 48(5). 703–712.
3.
Whelan, Jeremy, Rachel C. Jinks, Anne McTiernan, et al.. (2011). Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Annals of Oncology. 23(6). 1607–1616.
4.
Highley, Martin, Gareth Griffiths, Barbara Uscinska, et al.. (2009). A Phase II Trial of Continuous 5-Fluorouracil in Recurrent or Metastatic Transitional Cell Carcinoma of the Urinary Tract. Clinical Oncology. 21(5). 394–400.
5.
McTiernan, Anne, Gareth Morgan, Barbara Uscinska, et al.. (2008). The more it hurts, the better it works? Chemotherapy toxicity as a predictor of outcome from osteosarcoma: a report from the European Osteosarcoma Intergroup.. UCL Discovery (University College London).
6.
Lewis, Ian, M. Nooij, Jeremy Whelan, et al.. (2007). Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup. JNCI Journal of the National Cancer Institute. 99(2). 112–128.
7.
Nooij, M., Jeremy Whelan, V. Bramwell, et al.. (2004). Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. European Journal of Cancer. 41(2). 225–230.
8.
Nooij, M., Ian A. Lewis, J. T. Whelan, et al.. (2003). 693 Does increasing dose intensity in patients with operable osteosarcoma of the extremity improve outcome? A randomised controlled trial of the European Osteosarcoma Intergroup (EOI). European Journal of Cancer Supplements. 1(5). S209–S209.
9.
Weeden, Simon, R. J. Grimer, S. R. Cannon, A. H. M. Taminiau, & Barbara Uscinska. (2001). The effect of local recurrence on survival in resected osteosarcoma. European Journal of Cancer. 37(1). 39–46.
10.
Duchesne, Gillian, Gareth Griffiths, J.T. Roberts, et al.. (2000). A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. International Journal of Radiation Oncology*Biology*Physics. 47(2). 379–388.
11.
Fayers, Peter, A. Cuschieri, J W L Fielding, et al.. (2000). Sample size calculation for clinical trials: the impact of clinician beliefs. British Journal of Cancer. 82(1). 213–219.
12.
Voûte, P.A., R L Souhami, M. Nooij, et al.. (1999). A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. Annals of Oncology. 10(10). 1211–1218.
13.
Mead, Graham M., Mark A. Russell, Peter E. Clark, et al.. (1998). A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. British Journal of Cancer. 78(8). 1067–1075.
14.
Souhami, Robert L., Antonïe H.M. Taminiau, Jan W. van der Eijken, et al.. (1997). A Randomized Comparison of two Short Intensive Chemotherapy Regimens in Children and Young Adults With Osteosarcoma: Results in Patients With Metastases: A Study of the European Osteosarcoma Intergroup. Sarcoma. 1(3-4). 155–160.
15.
Souhami, Robert L., Alan Craft, Jan W. van der Eijken, et al.. (1997). Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. The Lancet. 350(9082). 911–917.
16.
Fosså, Sophie D., S. J. Harland, Stan B. Kaye, et al.. (1992). Initial Combination Chemotherapy with Cisplatin, Methotrexate and Vinblastine in Locally Advanced Transitional Cell Carcinoma—Response Rate and Pitfalls. British Journal of Urology. 70(2). 161–168.
17.
Roberts, J.T., Sophie D. Fosså, B. Richards, et al.. (1991). Results of Medical Research Council Phase II Study of Low Dose Cisplatin and Methotrexate in the Primary Treatment of Locally Advanced (T3 and T4) Transitional Cell Carcinoma of the Bladder. British Journal of Urology. 68(2). 162–168.
18.
Richards, B., Malin Parmar, C. K. Anderson, et al.. (1991). Interpretation of Biopsies of “Normal” Urothelium in Patients with Superficial Bladder Cancer. British Journal of Urology. 67(4). 369–375.
19.
Blackledge, G., Stuart Kaye, R. Taylor, et al.. (1989). A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder. European Journal of Cancer and Clinical Oncology. 25(2). 391–392.
20.
Tolley, David A., T. B. Hargreave, Philip H. Smith, et al.. (1988). Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). BMJ. 296(6639). 1759–1761.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Rudolf Schwarz Breakdown of academic impact, for papers by Janet Thomas Breakdown of academic impact, for papers by Rolf von Knobloch Breakdown of academic impact, for papers by Naji Salem Breakdown of academic impact, for papers by Eble Jn Breakdown of academic impact, for papers by Claudia Valverde Breakdown of academic impact, for papers by Hemant Tongaonkar Breakdown of academic impact, for papers by Tipu Nazeer Breakdown of academic impact, for papers by Daniel Kedar Breakdown of academic impact, for papers by Kyle Molberg